Common antioxidant enzyme catalase as COVID 19 treatment Elevated plasma level of the glycolysis byproduct methylglyoxal on admission is an independent biomarker of mortality in ICU COVID 19 patients Scientific Reports Frontiers Glutathione deficiency in the pathogenesis of SARS CoV 2 infection and its effects upon the host immune response in severe COVID 19 disease Coronavirus Pandemic Update 70: Glutathione Deficiency, Oxidative Stress, and COVID 19 How Glutathione IV Therapy Helps Combat COVID 19 Extivita RTP Evidence for structural protein damage and membrane lipid remodeling in red blood cells from COVID 19 patients medRxiv